Utama › Limfoma Sel Mantel › Ohio › Columbus
Kajian klinikal Limfoma Sel Mantel di Columbus, OH
11 kajian untuk Limfoma Sel Mantel sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Mengambil pesertaFasa 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mengambil pesertaFasa 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Ohio Health Research Institute, Columbus
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Mengambil pesertaFasa 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Mengambil pesertaFasa 1/2
- Research Site, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Mengambil pesertaFasa 1/2
- The Ohio State University Wexner Medical Center, Columbus
DALY II USA/ MB-CART2019.1 for DLBCL
Mengambil pesertaFasa 2
- The Ohio State University Wexner Medical Center James Cancer, Columbus
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Mengambil pesertaFasa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
Mengambil pesertaFasa 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Mengambil pesertaFasa 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Mengambil pesertaFasa 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Kajian Limfoma Sel Mantel di bandar lain
- Baldwin Park, CA15 kajian
- Houston, TX15 kajian
- Durham, NC13 kajian
- New York City, NY12 kajian
- Seattle, WA12 kajian
- Milwaukee, WI12 kajian
- Boston, MA11 kajian
- Nashville, TN11 kajian
- Chicago, IL10 kajian
- Portland, OR9 kajian
- Rochester, MN9 kajian
- St. Louis, MO8 kajian
Kajian lain di Columbus
- Kanser Paru-paru Bukan Sel Kecil56 kajian
- Kanser Payudara39 kajian
- Kanser Ovari39 kajian
- Kanser (semua jenis)38 kajian
- Kanser Paru-paru37 kajian
- Leukemia Mieloid Akut35 kajian
- Leukemia Limfositik Kronik28 kajian
- Kanser Metastatik27 kajian
- Kanser Endometrium25 kajian
- Kanser Kolorektal24 kajian
- Kanser Prostat24 kajian
- Mieloma Pelbagai24 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.